FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ALPHAGAN P (brimonidine tartrate), approving changes to the product labeling requested by Allergan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• ALPHAGAN P (BRIMONIDINE TARTRATE)

Snippet

SUPPL AP for ALPHAGAN P (BRIMONIDINE TARTRATE)